INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
03/17/2024
Back to search
Official data from USPTO
CLINTEC
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CLINTEC
ST13
US500000079100249Class
35, 41, 42, 45
Filing
79100249
Registration
4162941
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
55
Latest update
03/17/2024
Trademark type
Word
Nice classes
35, 41, 42, 45
Filing date
03/08/2011
Registration date
06/26/2012
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/24/2023
Last transaction
07/08/2023
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
Glasgow, GB
Examiner
CARROLL, DORITT
Law office
M70
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Clintec International Limited
Clintec International Limited
Representatives
Arlene D. Hanks Moore & Van Allen PLLC
Technical classification
Nice Classes
Class 35Class 41Class 42Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business consultation in the field of clinical research and pharmaceutical commercialisation; compilation and systemization of information into computer databases; database management for others of a database comprised of data collected for clinical and biostatistics research purposes; personnel recruitment and placement in the field of clinical research; compilation and provision of statistical analysis reports; statistical consulting services for pharmaceuticalbiotechnology and medical device industries for business purposes; creation and implementation of statistical analysis plans for business purposes; writing of business reports; business strategic planning ; market researchassessmentanalysis and evaluation; business feasibility studies
Class 41
Educational and training services in the field of clinical trials regulation and clinical research; Providingarranging and conducting workshopsseminarseducational conferences in the field of clinical trials regulation and clinical research; training in data capture and management; training and education in regulatory affairs; Providingarranging and conducting training and educational classesworkshopsseminarseducation conferences in medical writing; providingarranging and conducting training and educational classesworkshopsseminarseducation conferences training and education in quality controlauditing and inspection; writing of texts; training servicestraining of clinical and scientific researchers to conduct clinical research and drug development studies
Class 42
Scientific and technological services and research and design in the field of clinical trials and clinical research; industrial analysis and research services in the field of clinical trials and clinical research; clinical research servicesimplementation of clinical studies and providing reports thereon; management of scientific research projects; conducting clinical research projects in the field of clinical trials and clinical research; conducting and monitoring clinical trials ; quality audit servicesquality assurance consultancyquality control testing in the field of quality control for others; technical inspection servicesinspection of clinical dataclinical procedureclinical processclinical databaseclinical reports for others; pharmaceutical product evaluation; design and conducting of technical feasibility studies; drug development services; quality management of drug development; preparation of reports in relation to clinical trials and clinical researchincluding preparation of reports on management of scientific research projectsclinical research projectsclinical trialsauditspharmaceutical product evaluationsdrug development and pharmaceutical product evaluations
Class 45
Advisory and consultancy services relating to regulatory affairs in the field of clinical trialsclinical research and drug development; advisory and consultancy services relating to national and international regulation of clinical trials and drug development
Publications
History of USPTO decisions and trademark events.
55 publications found
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
02/03/2024
INPC
INVALIDATION PROCESSED
02/02/2024
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
01/24/2024
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
05/24/2023
71AG
REGISTERED-SEC.71 ACCEPTED
05/24/2023
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
05/22/2023
PR71
POST REGISTRATION ACTION MAILED - SEC.71
12/22/2022
XXXX
POST REGISTRATION ACTION CORRECTION
12/22/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/22/2022
ES71
TEAS SECTION 71 RECEIVED
06/29/2022
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
06/26/2021
RNWL
INTERNATIONAL REGISTRATION RENEWED
03/25/2021
NREP
NEW REPRESENTATIVE AT IB RECEIVED
01/22/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/15/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/15/2019
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
12/02/2017
C75A
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
12/02/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/01/2017
ES75
TEAS SECTION 71 & 15 RECEIVED
11/03/2017
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
06/26/2017
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/28/2014
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/28/2014
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/06/2013
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/06/2013
GPNX
NOTIFICATION PROCESSED BY IB
12/02/2012
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/15/2012
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/26/2012
FIMP
FINAL DISPOSITION PROCESSED
09/26/2012
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/26/2012
R.PR
REGISTERED-PRINCIPAL REGISTER
06/26/2012
CORR
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
05/17/2012
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
05/11/2012
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/10/2012
PUBO
PUBLISHED FOR OPPOSITION
04/10/2012
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/04/2012
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/04/2012
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/21/2012
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/05/2012
ALIE
ASSIGNED TO LIE
02/29/2012
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/11/2012
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/10/2012
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/10/2012
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/10/2012
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/18/2011
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/18/2011
RFNP
REFUSAL PROCESSED BY IB
08/27/2011
MAFR
APPLICATION FILING RECEIPT MAILED
08/11/2011
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/10/2011
RFRR
REFUSAL PROCESSED BY MPU
08/10/2011
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/10/2011
CNRT
NON-FINAL ACTION WRITTEN
08/09/2011
DOCK
ASSIGNED TO EXAMINER
08/08/2011
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/07/2011
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/04/2011
Continuous trademark protection
Get notified about every new filing that threatens CLINTEC or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.